NorthRock Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $862K | Sell |
2,217
-13
| -0.6% | -$5.06K | 0.02% | 269 |
|
|
2025
Q1 | $970K | Buy |
2,230
+158
| +8% | +$68.7K | 0.03% | 213 |
|
|
2024
Q4 | $764K | Sell |
2,072
-6
| -0.3% | -$2.21K | 0.02% | 250 |
|
|
2024
Q3 | $1.08M | Buy |
2,078
+45
| +2% | +$23.4K | 0.04% | 198 |
|
|
2024
Q2 | $1.1M | Buy |
2,033
+94
| +5% | +$50.9K | 0.04% | 183 |
|
|
2024
Q1 | $1.01M | Buy |
1,939
+182
| +10% | +$94.4K | 0.04% | 200 |
|
|
2023
Q4 | $829K | Buy |
1,757
+751
| +75% | +$354K | 0.03% | 218 |
|
|
2023
Q3 | $438K | Buy |
1,006
+196
| +24% | +$85.3K | 0.05% | 177 |
|
|
2023
Q2 | $360K | Sell |
810
-234
| -22% | -$104K | 0.04% | 184 |
|
|
2023
Q1 | $480K | Sell |
1,044
-290
| -22% | -$133K | 0.05% | 158 |
|
|
2022
Q4 | $684K | Buy |
1,334
+204
| +18% | +$105K | 0.08% | 125 |
|
|
2022
Q3 | $513K | Buy |
1,130
+137
| +14% | +$62.2K | 0.06% | 138 |
|
|
2022
Q2 | $479K | Buy |
993
+75
| +8% | +$36.2K | 0.05% | 160 |
|
|
2022
Q1 | $451K | Sell |
918
-41
| -4% | -$20.1K | 0.04% | 188 |
|
|
2021
Q4 | $444K | Buy |
959
+391
| +69% | +$181K | 0.03% | 190 |
|
|
2021
Q3 | $240K | Buy |
+568
| New | +$240K | 0.02% | 243 |
|